KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD  Lesley A. Inker, MD, Brad C. Astor, PhD, Chester.

Slides:



Advertisements
Similar presentations
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder.
Advertisements

Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study  Manjula Kurella Tamura,
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder.
Uric Acid and Long-term Outcomes in CKD
KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD  Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,
Frederik Persson, Peter Rossing  Kidney International Supplements 
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Prevalence of and Risk Factors.
Emilee R. Wilhelm-Leen, BA, Yoshio N. Hall, MD, Manjula K
American Journal of Kidney Diseases 
ESRD Care Within the US Department of Veterans Affairs: A Forward-Looking Program With an Illuminating Past  Suzanne Watnick, MD, Susan T. Crowley, MD 
Peritoneal dialysis American Journal of Kidney Diseases
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update
Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study  Manjula Kurella Tamura,
Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline  Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,
Empirically Derived Search Filters for the Development of Kidney Disease Clinical Practice Guidelines  Pavel S. Roshanov, MD, MSc, Arthur V. Iansavichus,
Edmund J. Bini, MD, MPH, Aditi Kinkhabwala, MD, David S. Goldfarb, MD 
Summary of Recommendation Statements
A Decade After the KDOQI CKD Guidelines
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Risk Factors for and Complications.
World Kidney Day 2014: CKD and the Aging Population
Joseph A. Vassalotti, MD, Beth Piraino, MD, Lynda A. Szczech, MD 
This Month in AJKD American Journal of Kidney Diseases
Risk Factors for ESRD in Individuals With Preserved Estimated GFR With and Without Albuminuria: Results From the Kidney Early Evaluation Program (KEEP) 
Recognition for Conservative Care in Kidney Failure
A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome
Advances in CKD Detection and Determination of Prognosis: Executive Summary of the National Kidney Foundation–Kidney Early Evaluation Program (KEEP) 2012.
Evaluation of the Potential Living Kidney Donor
Hai-yan Wang, MD, American Journal of Kidney Diseases
Focusing on Health Literacy Might Help Us Cross the Quality Chasm
Daniel E. Weiner, MD, MS  American Journal of Kidney Diseases 
National Kidney Foundation  American Journal of Kidney Diseases 
Salt and Hypertension American Journal of Kidney Diseases
Karl D. Nolph, MD, American Journal of Kidney Diseases
Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S
A Decade After the KDOQI CKD Guidelines: A Historical Perspective
This Month in AJKD American Journal of Kidney Diseases
The Map Is Not the Territory—Mapping Out the Course and Cost of CKD
Use of Diuretics in Heart Failure: A Precarious Balance
A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico
CPR 1.2.: Evaluation of Anemia in CKD
Nephrology: As It Was Then, But Is Not Now
by Simon DS Fraser, Paul J Roderick, and Maarten W Taal
Quiz page December 2004 American Journal of Kidney Diseases
Margaret T. Hicken, Ronit Katz, Deidra C. Crews, Holly J
American Journal of Kidney Diseases
Quiz Page April 2008 American Journal of Kidney Diseases
Study Designs in Patient-Oriented Research
Evidence and Outcomes in CKD
Within-Person Variability in Kidney Measures
Daniel T. Lackland, DrPH, David J.P. Barker, MD, PhD 
Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS 
Quiz Page August 2007 American Journal of Kidney Diseases
Arnold S. Relman, MD, American Journal of Kidney Diseases
Trial Quality in Nephrology: How Are We Measuring Up?
Making Music American Journal of Kidney Diseases
Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES),   Madhav V. Rao,
Achieving Fairness in Access to Kidney Transplant: A Work in Progress
Increased Urinary Albumin Excretion Following Recovery From Thrombotic Thrombocytopenic Purpura Due to Acquired ADAMTS13 Deficiency  Dustin J. Little,
This Month in AJKD American Journal of Kidney Diseases
MicroRNAs: A Macroview Into Focal Segmental Glomerulosclerosis
James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD 
This Month in AJKD American Journal of Kidney Diseases
Dialysis Research and N-of-1 Trials: Made for Each Other?
Paul M. Palevsky, MD, Kathleen D. Liu, MD, PhD, Patrick D
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
A Decade After the KDOQI CKD Guidelines: Impact on the National Kidney Foundation's Kidney Early Evaluation Program (KEEP)  Adam Whaley-Connell, DO, MSPH 
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Quiz page December 2003 American Journal of Kidney Diseases
This Month in AJKD American Journal of Kidney Diseases
What Should a Guideline Panel Do When Evidence Is Inconclusive
Presentation transcript:

KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD  Lesley A. Inker, MD, Brad C. Astor, PhD, Chester H. Fox, MD, Tamara Isakova, MD, James P. Lash, MD, Carmen A. Peralta, MD, Manjula Kurella Tamura, MD, Harold I. Feldman, MD, MSCE  American Journal of Kidney Diseases  Volume 63, Issue 5, Pages 713-735 (May 2014) DOI: 10.1053/j.ajkd.2014.01.416 Copyright © 2014 Terms and Conditions

Green: low risk (if no other markers of kidney disease, no CKD); Yellow: moderately increased risk; Orange: high risk; Red, very high risk. American Journal of Kidney Diseases 2014 63, 713-735DOI: (10.1053/j.ajkd.2014.01.416) Copyright © 2014 Terms and Conditions